Senores Pharmaceuticals Limited is an India-based company. The Company is engaged in the development and manufacturing of a pharmaceutical product. The Company manufactures products of international quality to cater to the increasing new age demands of the global healthcare industry. The Company's products include Acetaminophen + Butalbital Tablet, Candesartan Cilexetil + HCTZ Tablet, Losartan Potassium Tablet, Chlorzoxazone Tablet, Clomiphene Tablet, Deferiprone Tablet, Diltiazem ER Capsule, Enalapril Maleate Tablet, Escitalopram Tablet, Irbesartan Tablet, Olmesartan Medoxomil Tablet and others. It supplies affordable Active Pharmaceutical Ingredients (API) to generic formulations manufacturers. Its product API includes Anastrozole, Aripiprazole, Benfotiamine, Clomiphene Citrate, Desloratadine, Desvenlafaxine Succinate, Fluoxetine Hydrochloride, and others. Its domestic portfolio includes Immunosen - Human Normal Immunoglobulin, Senumin - Human Normal Albumin and others.
Senores Pharmaceuticals Ltd FAQs
How to Buy Senores Pharmaceuticals Ltd Share?
To purchase Senores Pharmaceuticals Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Senores Pharmaceuticals Ltd (ticker symbol: SENORES) on the trading platform provided by your broker and purchase the shares.
The stock price of Senores Pharmaceuticals Ltd as of 10 Jul 2026 is ₹1,400.99
What is the Market Cap of Senores Pharmaceuticals Ltd?
Market capitalisation represents the total market value of a company's outstanding shares. As of 10 Jul 2026, Senores Pharmaceuticals Ltd (ticker symbol: SENORES) has a market capitalisation of approximately ₹63,60,00,00,000.00
What is the PE and PB ratio of Senores Pharmaceuticals Ltd?
Senores Pharmaceuticals Ltd Ltd's price-to-book ratio as of 10 Jul 2026 is 8.21, reflecting the market's valuation compared to its asset value. As of 10 Jul 2026, the trailing twelve months P/E (price-to-earnings) ratio is 55.93, indicating the market values the company at around ₹55.93 for every ₹1 of earnings
What is the 52 Week High and Low of Senores Pharmaceuticals Ltd Share?
Senores Pharmaceuticals Ltd Ltd (SENORES) hit its 52-week high at ₹1,464.72, and its 52-week low at ₹575.30.